These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 18484643)

  • 1. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
    Zhao C; Austin RM
    Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone.
    Zhao C; Austin RM
    Gynecol Oncol; 2007 Nov; 107(2):231-5. PubMed ID: 17854873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very low human Papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests.
    Zhao C; Elishaev E; Yuan KH; Yu J; Austin RM
    Cancer; 2007 Oct; 111(5):292-7. PubMed ID: 17879368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk HPV DNA detected in less than 2% of over 25,000 cytology negative imaged liquid-based Pap test samples from women 30 and older.
    Bansal M; Austin RM; Zhao C
    Gynecol Oncol; 2009 Nov; 115(2):257-61. PubMed ID: 19665217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathologic follow-up and human papillomavirus DNA test results in 290 patients with high-grade squamous intraepithelial lesion Papanicolaou test results.
    Gao FF; Austin RM; Zhao C
    Cancer Cytopathol; 2011 Dec; 119(6):377-86. PubMed ID: 21774093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for cervical disease in mature women: strategies for improvement.
    Colgan TJ; Clarke A; Hakh N; Seidenfeld A
    Cancer; 2002 Aug; 96(4):195-203. PubMed ID: 12209660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
    Knoepp SM; Kuebler DL; Wilbur DC
    Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
    Cibas ES; Hong X; Crum CP; Feldman S
    Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS).
    Walker JL; Wang SS; Schiffman M; Solomon D;
    Am J Obstet Gynecol; 2006 Aug; 195(2):341-8. PubMed ID: 16890545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities.
    Zhao C; Zhao S; Heider A; Austin RM
    Arch Pathol Lab Med; 2010 Aug; 134(8):1130-5. PubMed ID: 20670132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytologic-histologic correlation of screening and diagnostic Papanicolaou tests.
    Chute DJ; Covell J; Pambuccian SE; Stelow EB
    Diagn Cytopathol; 2006 Jul; 34(7):503-6. PubMed ID: 16783779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reflex human papillomavirus DNA testing on residual liquid-based (TPPT) cervical samples: focus on age-stratified clinical performance.
    Sarode VR; Werner C; Gander R; Foster B; Fulmer A; Saboorian MH; Ashfaq R
    Cancer; 2003 Jun; 99(3):149-55. PubMed ID: 12811855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
    Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
    Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of high-risk human papillomavirus detection in women aged > or = 50 years with atypical squamous cells of undetermined significance cytologic preparations.
    Rosario D; Zahn CM; Bush AC; Kendall BS
    Cancer; 2007 Dec; 111(6):487-90. PubMed ID: 17973252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of human papillomavirus testing and endocervical component on pap tests: A pilot study using the Roche Cobas(®) assay.
    Pierce KJ; Currens HS; Tafe LJ; Tsongalis GJ; Padmanabhan V
    Diagn Cytopathol; 2016 Apr; 44(4):280-2. PubMed ID: 26801205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results.
    Bandyopadhyay S; Austin RM; Dabbs D; Zhao C
    Arch Pathol Lab Med; 2008 Dec; 132(12):1874-81. PubMed ID: 19061283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Squamous cervical lesions in women with human immunodeficiency virus: long-term follow-up.
    Massad LS; Seaberg EC; Wright RL; Darragh T; Lee YC; Colie C; Burk R; Strickler HD; Watts DH
    Obstet Gynecol; 2008 Jun; 111(6):1388-93. PubMed ID: 18515523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing cervical cancer detection using nucleic acid hybridization and acetic acid tests.
    Ficsor G; Fuller SK; Jeromin JL; Beyer RD; Janca FC
    Nurse Pract; 1990 Jul; 15(7):26, 29-30. PubMed ID: 2164177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
    Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
    Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
    Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.